Evidence map›Paper›PMID 15042404›Full record

ReviewWorld journal of urology2004

New insights into the pathology and molecular biology of human germ cell tumors.

Friedemann Honecker, J Wolter Oosterhuis, Frank Mayer, Jörg Thomas Hartmann, Carsten Bokemeyer, Leendert H J Looijenga

Abstract readReview
PubMed Publisher
In one paragraph

Review in World journal of urology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Friedemann HoneckerDepartment of Pathology, Josephine Nefkens Institute, Erasmus MC-University Medical Center Rotterdam, Daniel den Hoed Cancer Center, Room 430b, P.O. Box 1738 3000 DR Rotterdam, The Netherlands.
J Wolter Oosterhuis
Frank Mayer
Jörg Thomas Hartmann
Carsten Bokemeyer
Leendert H J Looijenga
University of Tübingen · DEErasmus MC Cancer Institute · NLErasmus University Rotterdam · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The group of human germ cell tumors (GCTs) is heterogeneous, and comprises neoplasms found at different anatomical locations. They are of interest not only for aspects of their tumor biology, but also from the point of view of developmental biology. GCTs show significant similarities to early germ cell development, most likely related to their cell of origin. Comparative analysis of the tumors and representative normal counterparts can therefore help to define events which are related to the pathogenesis of this cancer. Within the testis, three separate GCT entities have been identified, characterized by differing patho-biological, molecular/cytogenetic, and clinical observations, which will be described in more detail in this review. This article will highlight the most important contributions to the field in the last years. This includes the diagnostic value of OCT3/4, a transcription factor and marker for pluripotency. Furthermore, the invasive GCTs of young adults consistently show a gain of 12p-sequences, of which the exact role, including the gene(s) involved, remains to be elucidated, although interesting candidates have been identified. Finally, treatment sensitivity/resistance of GCTs most likely reflect the intrinsic characteristics of the cells of origin and their derivatives. The pluripotency of GCTs, in particular the possible loss of the embryonic characteristics and acquisition of somatic differentiation, could be a crucial phenomenon in this process.

Indexed as

GerminomaHumansMolecular BiologyNeoplasm Invasiveness

Identifiers

PMID15042404
OpenAlexW2013120348

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.